<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00372203</url>
  </required_header>
  <id_info>
    <org_study_id>06-0085-A</org_study_id>
    <nct_id>NCT00372203</nct_id>
  </id_info>
  <brief_title>Endobronchial Ultrasound vs Mediastinoscopy in NSCLC</brief_title>
  <official_title>Prospective Controlled Trial of Mediastinoscopy Compared With Endobronchial Ultrasound Guided Transbronchial Needle Aspiration for Assessment of the Mediastinum in Lung Cancer.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Proper staging of Lung cancer is of paramount concern when determining a treatment regime.&#xD;
      Currently the assessment of surgical candidacy is performed with the staging process, mainly&#xD;
      the mediastinoscopy. A mediastinoscopy has the ability to access samples of the paratracheal&#xD;
      lymph node stations (Levels 2R, 2L, 3, 4R, 4L), as well as the anterior subcarinal lymph node&#xD;
      station (Level 7). In comparison, the EBUS-TBNA technique is a real-time procedure that has&#xD;
      the potential to access the same paratracheal and subcarinal lymph node stations associated&#xD;
      with the mediastinoscopy, but also extending out to the hilar lymph nodes (Levels 10 and 11).&#xD;
      Because of the possibility of extended sampling range and a reduction in procedural&#xD;
      invasiveness, EBUS-TBNA may represent a more efficient patient centered alternative to&#xD;
      mediastinoscopy in the staging of lung cancer patients. Additionally, patients who are have&#xD;
      lymph nodes in the N2 region frequently undergo chemotherapy and/or radiotherapy prior to&#xD;
      surgery. Assessment of the lymph nodes after chemo/radiation is done using CT scans, as&#xD;
      re-mediastinoscopy is a technically difficult procedure. These patients may benefit from&#xD;
      EBUS-TBNA.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2006</start_date>
  <completion_date type="Actual">March 2010</completion_date>
  <primary_completion_date type="Actual">March 2010</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Non-small Cell Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Endobronchial ultrasound</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endobronchial Ultrasound Guided Transthoracic Needle Biopsy</intervention_name>
    <description>Endobronchial Ultrasound Guided Transthoracic Needle Biopsy of mediastinal lymph nodes at the time of the mediastinoscopy.</description>
    <arm_group_label>Endobronchial ultrasound</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        A) Age 18 years or older B) Patients with confirmed or suspected non-small cell lung cancer&#xD;
        who require a mediastinoscopy as part of their staging investigations of the mediastinum to&#xD;
        determine suitability for lung cancer resection will be considered for the trial.&#xD;
&#xD;
        C) Patients with undiagnosed enlarged lymph nodes in the mediastinum suspicious for lung&#xD;
        cancer in which a tissue diagnosis is required.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        A) Patients who are deemed on clinical grounds not to be medically fit for a bronchoscopy&#xD;
        or a mediastinoscopy or who are not suitable for definitive surgical resection by&#xD;
        thoracotomy will be excluded.&#xD;
&#xD;
        B) Patients who have verified stage IV disease or who are not appropriate for lung cancer&#xD;
        resection by virtue of direct invasion of mediastinal structures or large parts of the&#xD;
        chest wall.&#xD;
&#xD;
        C) Known small cell lung cancer. D) Patients where there is a high clinical suspicion of&#xD;
        lymphoma. E) Inability to give informed consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shaf Keshavjee, MD MSc FRCSC FACS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Health Network, Toronto</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Health Network (Toronto General Hospital)</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2C4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <study_first_submitted>September 4, 2006</study_first_submitted>
  <study_first_submitted_qc>September 4, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 6, 2006</study_first_posted>
  <last_update_submitted>May 3, 2017</last_update_submitted>
  <last_update_submitted_qc>May 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Non-small cell lung cancer</keyword>
  <keyword>NSCLC</keyword>
  <keyword>EBUS</keyword>
  <keyword>Endobronchial ultrasound</keyword>
  <keyword>mediastinoscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

